MesotheliomaPleural NeoplasmsClinical Trials as TopicAsbestosPeritoneal NeoplasmsZeolitesAsbestosisAsbestos, CrocidolitePleuraMesothelioma, CysticClinical Trials, Phase III as TopicClinical Trials, Phase II as TopicPleural Effusion, MalignantTreatment OutcomeAsbestos, AmphiboleCalbindin 2Clinical Trials, Phase I as TopicResearch DesignMineral FibersControlled Clinical Trials as TopicAsbestos, SerpentineDouble-Blind MethodNeoplasms, MesothelialLung NeoplasmsEpithelioid CellsTime FactorsAsbestos, AmositePatient SelectionOccupational DiseasesOccupational ExposureNeoplasmsAntineoplastic AgentsRandomized Controlled Trials as TopicGPI-Linked ProteinsMulticenter Studies as TopicGuanineTumor Markers, BiologicalPleural EffusionS100 Calcium Binding Protein GFollow-Up StudiesProspective StudiesPlacebosClinical Trials Data Monitoring CommitteesGlutamatesAntineoplastic Combined Chemotherapy ProtocolsClinical Trials, Phase IV as TopicCombined Modality TherapyClinical ProtocolsSurvival AnalysisCell Line, TumorCisplatinPrognosisSingle-Blind MethodDrug Administration ScheduleImmunohistochemistrySurvival RatePleural DiseasesEarly Termination of Clinical TrialsPleurisyTesticular Hydrocele